These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36483778)

  • 21. Overcoming the blood-brain barrier? - prediction of blood-brain permeability of hydrophobically modified polyethylenimine polyplexes for siRNA delivery into the brain with in vitro and in vivo models.
    Hartl N; Gabold B; Adams F; Uhl P; Oerter S; Gätzner S; Metzger M; König AC; Hauck SM; Appelt-Menzel A; Mier W; Fricker G; Merkel OM
    J Control Release; 2023 Aug; 360():613-629. PubMed ID: 37437848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Improved In Vitro Porcine Blood-Brain Barrier Model for Permeability Screening and Functional Studies.
    Patabendige A
    Methods Mol Biol; 2022; 2492():131-142. PubMed ID: 35733042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro Modeling of the Blood-Brain Barrier for the Study of Physiological Conditions and Alzheimer's Disease.
    Schreiner TG; Creangă-Murariu I; Tamba BI; Lucanu N; Popescu BO
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patented in vitro blood-brain barrier models in CNS drug discovery.
    Tóth A; Veszelka S; Nakagawa S; Niwa M; Deli MA
    Recent Pat CNS Drug Discov; 2011 May; 6(2):107-18. PubMed ID: 21585327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding parasite-brain microvascular interactions with engineered 3D blood-brain barrier models.
    Long RKM; Piatti L; Korbmacher F; Bernabeu M
    Mol Microbiol; 2022 Mar; 117(3):693-704. PubMed ID: 34837419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro models of the blood-brain barrier.
    Czupalla CJ; Liebner S; Devraj K
    Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Hybrid Nanofiber/Paper Cell Culture Platform for Building a 3D Blood-brain Barrier Model.
    Huang K; Castiaux A; Podicheti R; Rusch DB; Martin RS; Baker LA
    Small Methods; 2021 Sep; 5(9):. PubMed ID: 34541301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB).
    Booth R; Kim H
    Lab Chip; 2012 Apr; 12(10):1784-92. PubMed ID: 22422217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system.
    Cucullo L; Marchi N; Hossain M; Janigro D
    J Cereb Blood Flow Metab; 2011 Feb; 31(2):767-77. PubMed ID: 20842162
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Badawi AH; Mohamad NA; Stanslas J; Kirby BP; Neela VK; Ramasamy R; Basri H
    Curr Neuropharmacol; 2024; 22(8):1344-1373. PubMed ID: 38073104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simplified in vitro 3D co-culture-based blood-brain barrier model using transwell.
    Kim W; Kim J; Lee SY; Kim HM; Joo KM; Nam DH
    Biochem Biophys Res Commun; 2022 Sep; 620():63-68. PubMed ID: 35780582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research progress on the regulation and mechanism of borneol on the blood-brain barrier in pathological states: a narrative review focused on ischemic stroke and cerebral glioma.
    Tan X; Zhang K; Shi W; Tang Z
    Transl Cancer Res; 2023 Nov; 12(11):3198-3209. PubMed ID: 38130309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
    Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
    Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro modeling of the neurovascular unit: advances in the field.
    Bhalerao A; Sivandzade F; Archie SR; Chowdhury EA; Noorani B; Cucullo L
    Fluids Barriers CNS; 2020 Mar; 17(1):22. PubMed ID: 32178700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood-Brain Barrier and Neurodegenerative Diseases-Modeling with iPSC-Derived Brain Cells.
    Wu YC; Sonninen TM; Peltonen S; Koistinaho J; Lehtonen Š
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases.
    Chen X; Liu C; Muok L; Zeng C; Li Y
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery.
    Leite PEC; Pereira MR; Harris G; Pamies D; Dos Santos LMG; Granjeiro JM; Hogberg HT; Hartung T; Smirnova L
    Part Fibre Toxicol; 2019 Jun; 16(1):22. PubMed ID: 31159811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in Hydrogel-Based Microfluidic Blood-Brain-Barrier Models in Oncology Research.
    Sood A; Kumar A; Dev A; Gupta VK; Han SS
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic Acid-Conjugated Brush Polymers Show Enhanced Blood-Brain Barrier Crossing in Static and Dynamic
    Mazrad ZAI; Refaat A; Morrow JP; Voelcker NH; Nicolazzo JA; Leiske MN; Kempe K
    ACS Biomater Sci Eng; 2024 May; 10(5):2894-2910. PubMed ID: 38556768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
    Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
    Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.